Tianhong Shengjie Raises New Round to Accelerate Medical Device Commercialization

Tianhong Shengjie secured a new financing round to accelerate commercialization of its medical device portfolio in China.

Proceeds will support faster market launch, expanded manufacturing capacity, and broader sales coverage.

The company aims to reach more hospital and outpatient customers across China, including tier-1 and tier-2 cities.

The deal signals continued investor interest in Chinese medtech and in differentiated device pipelines.